A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors
NCT00437736
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
APO010
Sponsor
Valerio Therapeutics